For
Investors:

“Invest in the Future of Aging”

Join Mechanobiologics, Inc. in translating Nobel-worthy science into clinical-grade longevity solutions. Based on the legacy of Michael P. Sheetz, our LFU technology has extended lifespan in mice and reversed cellular senescence.

Join Our Investor Circle

For
Collaborators:

“Collaborate with a Legacy of Innovation”

Are you a scientist or clinician working on aging, cancer, or regenerative medicine? Partner with Mechanobiologics, Inc. to pilot LFU in your lab or practice.

Request a Collaboration Meeting

For
General Interest:

“Stay Ahead of the Curve”

Be the first to hear about our clinical trial results, device launches, and breakthroughs in cellular rejuvenation.

Subscribe to Updates

Pioneering longevity and enhanced healthspan through mechanobiology and low frequency ultrasound (LFU) rejuvenation

Groundbreaking research pioneered by the late Michael P. Sheetz,
Mechanobiologics, Inc. is redefining longevity science.

Pioneering longevity and enhanced healthspan through mechanobiology and low frequency ultrasound (LFU) rejuvenation

Pioneered by the late Michael P. Sheetz, Mechanobiologics, Inc.
is redefining longevity science.

Pioneering longevity and enhanced healthspan through mechanobiology and low frequency ultrasound (LFU) rejuvenation

Pioneered by the late Michael P. Sheetz, Mechanobiologics, Inc.
is redefining longevity science.

For Investors:

For Collaborators:

For General Interest:

Pioneering longevity and enhanced healthspan through mechanobiology and low frequency ultrasound (LFU) rejuvenation

Pioneering longevity and enhanced healthspan through mechanobiology and low frequency ultrasound (LFU) rejuvenation

Pioneering longevity and enhanced healthspan through mechanobiology and low frequency ultrasound (LFU) rejuvenation

For
Investors:

For
Collaborators:

For
General Interest: